Dergiler / Selçuk Tıp Dergisi / 2021 / Cilt: 37 - Sayı: 3

Evaluation of Kidney Functions After Nephrectomy: Single Center Experience

Nefrektomi Sonrası Böbrek Fonksiyonunun Değerlendirilmesi: Tek Merkez Deneyimi

Sayfa
[218]–223
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, preventive measures should be taken in a timely manner to reduce the prevalence of nephrectomies due to benign diseases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: In this study, it was aimed to investigate the kidney function, hypertension development and proteinuria in individuals with only one kidney .
📊
Temel Bulgular & Veri:Patients and Methods: The study included 96 patients who had previously undergone nephrectomy with the causes of nephrolithiasis and chronic pyelonephritis-induced nonfunctional kidney, RCC (Renal Cell carcinoma), trauma, and donor nephrectomy among 17800 patients who applied to the Siirt State Hospital Nephrology and Urology outpatient clinics between January 2016 and December 2019.
💡
Sonuç & Katkı:Therefore, preventive measures should be taken in a timely manner to reduce the prevalence of nephrectomies due to benign diseases.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: In this study, it was aimed to investigate the kidney function, hypertension development and proteinuria in individuals with only one kidney . Patients and Methods: The study included 96 patients who had previously undergone nephrectomy with the causes of nephrolithiasis and chronic pyelonephritis-induced nonfunctional kidney, RCC (Renal Cell carcinoma), trauma, and donor nephrectomy among 17800 patients who applied to the Siirt State Hospital Nephrology and Urology outpatient clinics between January 2016 and December 2019. The data of the patients were obtained from patient files database retrospectiv ely. Results: A total of 96 patients, 45 female and 51 male, were included in the study. 23 (24%) of the patients had donor nephrectomy (DN), and 73 (76%) had nephrectomy (DE) due to nephrolithiasis, chronic pyelonephritis, trauma, and renal cell cancer (RCC). The patients were divided into two groups as those who underwent DN and DE due to other etiologies. Between DN and DE group, there was no statistically significant difference in terms of mean age, distribution of gender, presence of HT before nephrectomy, DM, presence of hematuria and new onset proteinuria (P> 0.05). Compared to the DN group, the frequency of new onset in CKD and HT development was significantly higher DE group. Conclusion: Nephrectomy is a risk factor for the development of CKD, proteinuria and hypertension. Therefore, preventive measures should be taken in a timely manner to reduce the prevalence of nephrectomies due to benign diseases.

Abstract

Amaç: Bu çalışmada tek böbreği kalan bireylerde böbrek fonksiyonu, hipertansiyon gelişimi ve proteinüriyi araştırmak amaçlanmıştır. Hastalar ve Yöntem: Çalışmaya Ocak 2016-Aralık 2019 tarihleri arasında çeşitli nedenlerle Siirt Devlet Hastanesi Nefroloji ve Üroloji polikliniklerine başvuran 17800 hasta arasından daha önce nefrolitiyazis ve kronik piyelonefrite bağlı nonfonksiyone böbrek, RCC (Renal Cell Karsinom), travma ve donör nefrektomi nedeniyle nefrektomi yapılmış 96 hasta dahil edildi. Hastaların verileri retrospektif olarak hasta dosyalarından elde edildi. Bulgular: Çalışmaya 45’i kadın 51’i erkek olmak üzere toplam 96 hasta dahil edildi. Hastaların 23’üne (% 24) donör nefrektomi (DN) yapılmış, 73’üne (%76) nefrolitiyazis, kronik piyelonefrit, travma ve Renal Cell Hücreli Kanser (RCC) nedeniyle nefrektomi yapılmıştı. Hastalar DN yapılanlar ve diğer etyolojiler nedeniyle nefrektomi (DE) yapılan hastalar olarak iki gruba ayrıldı. DN grubu ile DE grubu arasında sırasıyla; yaş ortalamaları, kadın erkek dağılımı, nefrektomi öncesi HT varlığı, DM, hematüri ve yeni başlangıçlı proteinüri varlığı yönünden karşılaştırıldığında istatistiksel olarak anlamlı farklılık görülmedi (P>0.05). DN grubuna göre DE grubunda yeni başlangıçlı KBH ve HT gelişme sıklığı istatistiksel anlamlı olarak daha yüksek idi (P<0.05). Sonuç: Nefrektomi KBH, proteinüri ve HT gelişimi için risk faktörüdür. Bu nedenle benign hastalıklar nedeniyle yapılan nefrektomilerin prevalansını azaltmak için za manında önleyici tedbirler alınmalıdır .

🔖

Bu Makaleye Atıf Yap

SARİTAS, H., OK, F., ERDOĞAN, Ö. (2021). Evaluation of Kidney Functions After Nephrectomy: Single Center Experience. Selçuk Tıp Dergisi, Cilt: 37 - Sayı: 3, [218]–223. https://ajindex.com/articles/390591

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Tantisattamo E, Dafoe DC, Reddy UG, et al. Current management of acquired solitary kidney. Kidney Int Rep 2019;4(9):1205-18.
  2. Lopau K, Wanner C. Treatment rationale for coronary heart disease in advanced CKD Herz 2021:1-6. Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014;86(1):162-7.
  3. Muzaale AD, Massie AB, Wang M-C, et al. Risk of end-stage renal disease following live kidney donation. J Am Med Assoc 2014;311(6):579-86.
  4. Grams ME, Sang Y, Levey AS, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016;374(5):411-21.
  5. Kim S, Chang Y, Lee YR, et al. Solitary kidney and risk of chronic kidney disease. Eur j Epidemiol 2019;34(9):879-88.
  6. Massie AB, Holscher CM, Henderson ML, et al. Association of early postdonation renal function with subsequent risk of end-stage renal disease in living kidney donors. J Am Med Assoc Surg 2020;155(3):e195472-e. Ellis RJ. Chronic kidney disease after nephrectomy: A clinically-significant entity? Transl Androl Urol 2019;8(Suppl 2):S166. Zhang WJ, Wang ZY, Zhou WX, et al. Identifying risk factors for chronic kidney disease stage 3 in adults with acquired solitary kidney from unilateral nephrectomy: A retrospective cohort study. BMC Nephrol 2020;21(1):1-10. Madias NE. Metabolic acidosis and CKD progression.Clin J Am Soc Nephrol 2021;16(2):310-2.
  7. Matas AJ, Vock DM, Ibrahim HN. GFR≤ 25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD Am J Transplant 2018;18(3):625-31.
  8. Raheem OA, Khandwala YS, Sur RL, et al. Burden of urolithiasis: Trends in prevalence, treatments, and costs. Eur Urol Focus 2017;3(1):18-26.
  9. Fournier C, Pallet N, Cherqaoui Z, al. Very long-term followup of living kidney donors. Transpl Int 2012;25(4):385-90.
  10. Saxena AB, Myers BD, Derby G, et al. Adaptive hyperfiltration in the aging kidney after contralateral nephrectomy. Am J Physiol Renal Physiol 2006;291(3):F629-34. Brenner BM, MacKenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 1997;63:S124-7. Hagos M. Indications and outcomes of nephrectomy in ayder comprehensive specialized and mekelle hospitals, northern ethiopia: A 5 year experience. Ethiop Med J 2019;57(1):13-8.
  11. Lentine KL, Lam NN, Segev DL. Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol 2019;14(4):597-608.
  12. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and manage